Medicine and Dentistry
Breast Cancer
100%
Radiation Therapy
66%
Cervical Cancer
46%
Systemic Therapy
38%
Intensity Modulated Radiation Therapy
36%
Neoplasm
34%
Carcinoma
34%
Malignant Neoplasm
32%
Brachytherapy
29%
Intracavitary Brachytherapy
21%
Diseases
20%
Physical Activity
20%
Radiation Oncology
20%
Magnetic Resonance Imaging
18%
Recurrent Disease
17%
Cancer
17%
Melanoma
17%
Cervix
17%
Bladder
15%
Pelvic Radiotherapy
14%
Gamma Urogastrone
13%
Neoadjuvant Chemotherapy
13%
Epidermal Growth Factor Receptor
13%
Bevacizumab
13%
Letrozole
13%
Postmenopause
13%
Arm
13%
Cancer Therapy
13%
Treatment Planning
12%
Overall Survival
11%
Vegetable Consumption
11%
Quality of Life
11%
Lymph Node
11%
Estrogen Receptor
11%
Clinical Trial
10%
Drug Megadose
10%
Low Drug Dose
10%
Radiation Oncologist
9%
Mastectomy
9%
Cancer Research
9%
Uterine Cancer
9%
Pelvis
8%
Neck
8%
Magnetic Resonance Imaging of Breast
8%
Second Cancer
8%
Fruit Consumption
8%
Randomized Controlled Trial
8%
Breast Radiotherapy
7%
Physical Performance
7%
Interstitial Brachytherapy
7%
Keyphrases
Cervical Cancer
37%
Consensus Guidelines
34%
Breast Cancer
29%
Neoadjuvant Systemic Therapy
29%
Pathological Complete Response
27%
Gardening Intervention
27%
Clinical Target Volume
26%
Radiation Therapy
24%
Magnetic Resonance Imaging
23%
Intensity-modulated Radiotherapy
22%
Vegetable Gardens
21%
Organs at Risk
21%
Physical Activity
20%
American Brachytherapy Society
20%
Bevacizumab
20%
Cervical Carcinoma
20%
Radiation Oncology
20%
Invasive Breast Cancer
18%
Pathological Response
17%
Cancer Survivors
17%
Intensity-modulated Radiation Therapy
15%
Newly Diagnosed
15%
Brachytherapy
15%
Bladder
15%
Home-based
15%
Accelerated Partial Breast Irradiation
14%
Intracavitary Brachytherapy
14%
HDR Brachytherapy
14%
Breast Cancer Treatment
14%
Pelvic Radiotherapy
14%
Postmastectomy Radiation Therapy
13%
Breast Magnetic Resonance Imaging
13%
Head-and-neck Cancer
13%
Early Breast Cancer
13%
University of Alabama at Birmingham
13%
Intensity-modulated
13%
Letrozole
13%
Image-based
13%
Postmenopausal Women
13%
Neoadjuvant Chemotherapy
13%
Overall Survival
12%
Chemotherapy
12%
Patient Selection
12%
Locally Advanced Cervical Cancer
11%
Omission of Surgery
11%
Tumor
11%
Vegetable Consumption
11%
Radiotherapy
11%
High Dose
11%
Randomized Trial
10%